These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 30630241)

  • 1. [Expert Consensus on Short-Course Therapy of Multi-drug Resistant Tuberculosis].
    ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2019 Jan; 42(1):5-8. PubMed ID: 30630241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges and Outlooks in Multi-drug Resistant Tuberculosis.
    Caminero Luna JA
    Arch Bronconeumol; 2017 Aug; 53(8):417-418. PubMed ID: 28314633
    [No Abstract]   [Full Text] [Related]  

  • 3. [Chinese expert consensus on multidrug-resistant tuberculosis and Rifampicin-resistant tuberculosis treatment].
    Chinese Society of Tuberculosis of Chinese Medical Association
    Zhonghua Jie He He Hu Xi Za Zhi; 2019 Oct; 42(10):733-749. PubMed ID: 31594107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clofazimine in treatment of multi-drug resistant tuberculosis].
    Jing W; Wang QF; Chu NH
    Zhonghua Jie He He Hu Xi Za Zhi; 2016 May; 39(5):396-9. PubMed ID: 27180598
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug-resistant tuberculosis.
    Böttger EC
    Lancet; 2001 Apr; 357(9264):1288-9. PubMed ID: 11421208
    [No Abstract]   [Full Text] [Related]  

  • 6. Multidrug-Resistant Tuberculosis in Child Successfully Treated with 9-Month Drug Regimen.
    Achar J; Berry C; Herboczek K; Parpieva N; Tillyashaykhov MN; Tigay ZN; Khamraev A; Velivela K; Seddon JA; du Cros P
    Emerg Infect Dis; 2015 Nov; 21(11):2105-6. PubMed ID: 26488556
    [No Abstract]   [Full Text] [Related]  

  • 7. Multidrug resistant tuberculosis: a continuing crisis.
    Burki T
    Lancet Infect Dis; 2016 Dec; 16(12):1337-1338. PubMed ID: 27998601
    [No Abstract]   [Full Text] [Related]  

  • 8. Emergence of extensive drug resistance during treatment for multidrug-resistant tuberculosis.
    Cox HS; Sibilia K; Feuerriegel S; Kalon S; Polonsky J; Khamraev AK; Rüsch-Gerdes S; Mills C; Niemann S
    N Engl J Med; 2008 Nov; 359(22):2398-400. PubMed ID: 19038891
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of Multidrug-Resistant Tuberculosis Infection in Children.
    Cruz AT; Garcia-Prats AJ; Furin J; Seddon JA
    Pediatr Infect Dis J; 2018 Oct; 37(10):1061-1064. PubMed ID: 30216296
    [No Abstract]   [Full Text] [Related]  

  • 10. Fluoroquinolones in multidrug-resistant tuberculosis.
    Mohapatra PR
    Am J Respir Crit Care Med; 2004 Oct; 170(8):920-1. PubMed ID: 15475406
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug-resistant Mycobacterium tuberculosis, Taiwan.
    Jou R; Chuang PC; Wu YS; Yan JJ; Luh KT
    Emerg Infect Dis; 2006 May; 12(5):871-2. PubMed ID: 16710962
    [No Abstract]   [Full Text] [Related]  

  • 12. How Do the New Definitions for Multidrug-Resistant Tuberculosis Treatment Outcomes Really Perform?
    Gebhard A; van den Hof S; Cobelens F
    Am J Respir Crit Care Med; 2015 Jul; 192(1):117. PubMed ID: 26131997
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy and safety of regimens for drug-resistant tuberculosis.
    Yates TA; Nunn AJ
    Lancet Infect Dis; 2016 Nov; 16(11):1218-1219. PubMed ID: 27788973
    [No Abstract]   [Full Text] [Related]  

  • 14. Emerging resistant clone of Mycobacterium tuberculosis in west Asia.
    Mokrousov I
    Lancet Infect Dis; 2016 Dec; 16(12):1326-1327. PubMed ID: 27998587
    [No Abstract]   [Full Text] [Related]  

  • 15. Pakistan's battle with multi-drug resistant tuberculosis--establishing the ground rules.
    Saleem T; Khalid U
    J Pak Med Assoc; 2012 Jan; 62(1):80. PubMed ID: 22352115
    [No Abstract]   [Full Text] [Related]  

  • 16. Reply: How Do the New Definitions for Multidrug-Resistant Tuberculosis Treatment Outcomes Really Perform?
    Bastard M; Bonnet M; du Cros P; Khamraev AK; Hayrapetyan A; Kimenye K; Khurkhumal S; Dlamini T; Telnov A; Sanchez-Padilla E; Hewison C; Varaine F
    Am J Respir Crit Care Med; 2015 Jul; 192(1):117-8. PubMed ID: 26131996
    [No Abstract]   [Full Text] [Related]  

  • 17. Resistant plus susceptible tuberculosis: the undiscovered country.
    Ahmad Khan F; Behr M
    J Infect Dis; 2014 Jun; 209(11):1682-4. PubMed ID: 24523512
    [No Abstract]   [Full Text] [Related]  

  • 18. Direct observation therapy-plus can prevent acquired resistance to fluoroquinolones among patients with multidrug-resistant tuberculosis in Taiwan.
    Chien JY; Lai CC; Tan CK; Yu CJ; Hsueh PR
    Clin Infect Dis; 2013 Apr; 56(7):1054-5. PubMed ID: 23175554
    [No Abstract]   [Full Text] [Related]  

  • 19. Rapid emergence of
    Veziris N; Bernard C; Guglielmetti L; Le Du D; Marigot-Outtandy D; Jaspard M; Caumes E; Lerat I; Rioux C; Yazdanpanah Y; Tiotiu A; Lemaitre N; Brossier F; Jarlier V; Robert J; Sougakoff W; Aubry A; ;
    Eur Respir J; 2017 Mar; 49(3):. PubMed ID: 28182568
    [No Abstract]   [Full Text] [Related]  

  • 20. A Collaborative Approach for "ReSeq-ing" Mycobacterium tuberculosis Drug Resistance: Convergence for Drug and Diagnostic Developers.
    Schito M; Dolinger DL
    EBioMedicine; 2015 Oct; 2(10):1262-5. PubMed ID: 26629499
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.